Görüntüleme
8
Mukokutanöz lenf nodu sendromu olarak da bilinen Kawasaki hastalığı (KH), kendini sınırlayan orta çaplı musküler arter vasküliti olup, gelişmiş ülkelerdeki çocuklarda edinilmiş kalp hastalığının en yaygın nedenidir. Hastalık çoğunlukla 5 yaşın altındaki çocukları etkiler. KH’ nin tedavisinde intravenöz immünoglobulin (IVIG) ile birlikte asetil salisilik asit (ASA) kullanımı standart tedavi olarak kabul edilir. Yaşam boyu tromboz, koroner stenoz, miyokard enfarktüsü, kalsifikasyonlar, dev koroner arter anevrizması rüptürü ve ani ölüm gibi komplikasyonları olan bu çocukluk çağı hastalığının, erken tanı ve tedavisi çok önemlidir. KH’ de oral bulguların sıkça görülmesi, özellikle pediatrik diş hekimlerinin KH tanısında rol alabileceğini gösterir. Ayrıca KH bulguları, tedavisi ve komplikasyonları dental tedavi prosedürleri sırasında diş hekimlerinin hastalara yaklaşımlarını etkiler. Bu derlemenin amacı, tüm dünyayı etkileyen COVID-19 pandemisi döneminde yeniden gündeme gelen KH hakkındaki güncel bilgileri paylaşmak ve bu hastaların dental tedavileri sırasında diş hekimlerinin yaklaşımlarına yol gösterici olmaktır.
The disease of Kawasaki, also known as the mukocutanous lymph nod syndrome (KH), is a self-restricted medium-dimensional muscular arterial vasculitis and is the main cause of acquired heart disease in children in developed countries. The disease affects mostly children under the age of 5. In the treatment of KH, the use of acetylsalicylic acid (ASA) along with intravenous immunoglobulin (IVIG) is considered standard treatment. Early diagnosis and treatment of this childhood disease, with complications such as lifelong thrombosis, coronary stenosis, myocardial infarction, calcifications, giant coronary arterial aneurysm ruptura and sudden death, is very important. The frequent observation of oral findings in KH indicates that pediatric dentists can play a role in the diagnosis of KH. Also, KH findings, treatment and complications affect the dentist’s approach to patients during dental treatment procedures. The purpose of this collection is to share the current information about the KH that was re-established during the COVID-19 pandemic period that affected the whole world and to be a guide to the approaches of the dentists during dental treatments for these patients.
Kawasaki disease (KD), also known as mucocutaneous lymph node syndrome, is a self-limiting medium-sized muscular artery vasculitis and is the most common cause of acquired heart disease in children in developed countries. The disease mostly affects children under 5 years old. In the treatment of KD, use of intravenous immunoglobulin (IVIG) together with acetylsalicylic acid (ASA) is accepted as the standard treatment. Early diagnosis and treatment is very important in this childhood disease, which has life-long complications such as thrombosis, coronary stenosis, myocardial infarction, calcifications, the rupture of giant coronary artery aneurysm and sudden death. The frequent occurrence of oral symptoms in KD indicates that pediatric dentists may play a role in the diagnosis of KD. Also, the symptoms, treatment and complications of KD affect the approach of dentists to patients during dental treatment procedures. The aim of this review is to share current information about KD which has come to the agenda during the COVID-19 pandemic that affected the world, and to guide the dentist's approaches during dental treatment of these patients.
Alan : Sağlık Bilimleri
Dergi Türü : Uluslararası
Makale Detay 
Benzer Makaleler
PDF Görüntüle
Dergi Bilgisi
Eseri Dinleyin
Alıntı Yap
Bu Sayfayı Yazdırın
Paylaş
Mendeley
